loading page

Caveolin-3: a molecular insight into diseases of the heart
  • +2
  • Miaomiao He,
  • Jie Qiu,
  • Yan Wang,
  • Yang Bai,
  • Guangzhi Chen
Miaomiao He
Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology
Author Profile
Jie Qiu
Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology
Author Profile
Yan Wang
Tongji Hospital, Tongji Medical College,Huazhong University of Science and Technology
Author Profile
Yang Bai
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Author Profile
Guangzhi Chen
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Corresponding Author:[email protected]

Author Profile

Abstract

Caveolin-3 is protein on the membrane of cardiac myocytes correlated with a variety of cardiovascular diseases. The functional significance of the Cav-3 has been proved by the fact that Cav-3 overexpression or knockdown results in the occurrence and development of cardiovascular disease. Mutations in the gene encoding Cav-3 cause a broad spectrum of clinical phenotypes, ranging from isolated hyperCKemia to most cardiomyopathy and the effect of cav-3 mutations on current density parallels the effect on channel trafficking. Mutations in the Cav-3 gene, such as F97C and S141R, promote ventricular arrhythmogenesis in LQT9 by combined decrease in loss of IK1 and gain of Ina-L. Major changes in the T-tubule system by Cav-3 mutation, which contribute to the regulation of Ca2+ channels, result Cardiac hypertrophy. Furthermore, Cav-3 knockdown (KO) could induce apoptosis initiated by myocardial ischemia/reperfusion injury and many materials, such as volatile anesthetic gas, facilitate cardioprotection by involving AMP-activated protein kinase (AMPK) and cav-3 dependent cyclooxygenase-2 inhibition. This review highlights the overviews that the roles of Cav-3 play in cardiovascular disease, particularly on the arrhythmias and cardiomyopathy.